- Comments on Tegaserod Trial on Irritable Bowel Syndrome
-
Jung HK
- KMID: 2326151
- J Neurogastroenterol Motil.
- 2010 Apr;16(2):222-222.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Risks associated with sunitinib use and monitoring to improve patient outcomes
-
Choi BS
- KMID: 1792008
- Korean J Intern Med.
- 2014 Jan;29(1):23-26.
- doi: 10.3904/kjim.2014.29.1.23
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Extensive skin color change caused by extravasation of indigo carmine
-
Choi JW, Lee JJ, Kim GH, Hong SH
- KMID: 2243834
- Korean J Anesthesiol.
- 2012 May;62(5):499-500.
- doi: 10.4097/kjae.2012.62.5.499
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Cardiac arrest from intravenous indigo carmine during laparoscopic surgery: A case report
-
Lee WJ, Jang HS
- KMID: 2236458
- Korean J Anesthesiol.
- 2012 Jan;62(1):87-90.
- doi: 10.4097/kjae.2012.62.1.87
Indigo carmine (sodium indigotindisulfonate) is a safe, biologically inactive blue dye routinely administered intravascularly during urologic and gynecologic procedures to localize the ureteral orifices and to identify severed ureters and... -
- CITED
-
- Close
- SHARE
-
- Close
- Hypotension in patients administered indigo carmine containing impurities: A case report
-
Kim SH, Suk EH, Kil SH, Hahm KD, Hwang JH
- KMID: 2092328
- Korean J Anesthesiol.
- 2011 Nov;61(5):435-438.
- doi: 10.4097/kjae.2011.61.5.435
Indigo carmine has been used for eight decades with few adverse effects. Several of our patients, however, experienced severe hypotensive episodes after indigo carmine administration within a period of one... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Sunitinib-Induced Destructive Thyroiditis
-
Kim BK, Choi YS, Park YH
- KMID: 2134821
- Endocrinol Metab.
- 2012 Mar;27(1):68-71.
- doi: 10.3803/EnM.2012.27.1.68
Sunitinib is a multi-targeted tyrosine-kinase inhibitor used for gastrointestinal stromal tumors and renal cell carcinoma (RCC). Several recent studies have reported sunitinib-induced hypothyroidism and thyroid dysfunction; however, the underlying mechanisms... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of thyrotoxicosis after sunitinib treatment
-
Lee HY, Kim MK, Kim NK, Kim HS, Ryu SY, Kwon KY, Park KG
- KMID: 2259167
- Korean J Med.
- 2010 Apr;78(4):503-506.
Sunitinib is a tyrosine-kinase inhibitor used to treat metastatic renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumors. Hypothyroidism is a common side effect of sunitinib therapy. Nevertheless, overt thyrotoxicosis induced by... -
- CITED
-
- Close
- SHARE
-
- Close
- Profound Hypotension after an Intradermal Injection of Indigo Carmine for Sentinel Node Mapping
-
Jo YY, Lee MG, Yun SY, Lee KC
- KMID: 2374557
- J Breast Cancer.
- 2013 Mar;16(1):127-128.
Intradermal injections of indigo carmine for sentinel node mapping are considered safe and no report of an adverse reaction has been published. The authors described two cases of profound hypotension... -
- CITED
-
- Close
- SHARE
-
- Close
- Plant Hormones Promote Growth in Lichen-Forming Fungi
-
Wang XY, Wei XL, Luo H, Kim JA, Jeon HS, Koh YJ, Hur JS
- KMID: 1457452
- Mycobiology.
- 2010 Sep;38(3):176-179.
- doi: 10.4489/MYCO.2010.38.3.176
The effect of plant hormones on the growth of lichen-forming fungi (LFF) was evaluated. The use of 2,3,5-triiodobenzoic acid and indole-3-butyric acid resulted in a 99% and 57% increase in... -
- CITED
-
- Close
- SHARE
-
- Close
- Patient with Malignant Granular Cell Tumor Treated with Sunitinib Malate
-
Lee SJ, Kim JH, Cho HW, Na GJ, Kim HJ, Bae SB, Lee KT
- KMID: 2317687
- Soonchunhyang Med Sci.
- 2012 Jun;18(1):66-69.
Malignant granular cell tumors (MGST) are extremely rare, high-grade sarcoma of schwann cell origin. They often metastasize and are associated with short survival. We described a patient with recurred MGST... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Hand-Foot Syndrome with Pustules and Paronychia Induced by Sunitinib
-
Choi JW, Kim SW, Woo SM, Won CH, Cho S
- KMID: 2248073
- Korean J Dermatol.
- 2008 Oct;46(10):1384-1386.
In January 2006, Sunitinib was approved by the US Food and Drug Administration for the treatment of advanced renal cell carcinoma and gastrointestinal stromal tumor. Sunitinib inhibits the receptor tyrosine... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Hand-Foot Syndrome Induced by Sunitinib
-
Jeong JS, Yun JH, Yoon SJ, Kim WJ, Lee JY, Yoon TY
- KMID: 1484230
- Korean J Dermatol.
- 2008 Sep;46(9):1236-1239.
Sunitinib (SU11248) is a novel orally administered small molecule that inhibits multiple receptor tyrosine kinases so that can block tumor growth and angiogenesis. It was approved on 2006, for the... -
- CITED
-
- Close
- SHARE
-
- Close
- Sunitinib-induced hypothyroidism
-
Chung YJ
- KMID: 1458427
- Korean J Med.
- 2010 Nov;79(5):506-508.
Sunitinib is an oral multi-targeted tyrosine kinase inhibitor that is effective for advanced renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor. Currently, sunitinib is being investigated in multiple other tumor... -
- CITED
-
- Close
- SHARE
-
- Close
- Angiogenic Inhibitor Induced Complicated Reflux Esophagitis
-
Ryu JI, Jung HK, Cho MS, Lee MJ, Song ME, Oh DY, Song HE
- KMID: 2284016
- Ewha Med J.
- 2013 Mar;36(1):58-61.
- doi: 10.12771/emj.2013.36.1.58
Sunitinib an inhibitor of the vascular endothelial growth factor receptor, is highly effective against renal cell carcinoma and is now widely used in patients with metastatic disease. Gastroesophageal reflux disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Therapeutic Effect of Sunitinib by 11C-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma
-
Oyama N, Takahara N, Hasegawa Y, Tanase K, Miwa Y, Akino H, Okazawa H, Kudo T, Fujibayashi Y, Yokoyama O
- KMID: 1447599
- Nucl Med Mol Imaging.
- 2011 Sep;45(3):217-219.
Although sunitinib shows a high response rate in patients with untreated metastatic renal cell carcinoma (mRCC), quite a few patients show no therapeutic effect. Therefore, it is crucial to distinguish... -
- CITED
-
- Close
- SHARE
-
- Close
- New Systemic Treatment for Malignant Melanoma
-
Lee SJ, Chae YS
- KMID: 2267785
- Korean J Med.
- 2013 Oct;85(4):357-363.
Although early stage melanoma can be cured by complete resection, the prognosis of the patients with unresectable or metastatic disease is dismal with the overall survival less than 1 year... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Bullous Fixed Drug Eruption Coexisting with Hand-Foot Syndrome and This Was Induced by Sunitinib
-
Jeong TJ, Lee EJ, Jeong KH, Shin MK, Kim NI
- KMID: 2247829
- Korean J Dermatol.
- 2009 Jun;47(6):739-742.
Sunitinib is multitargeted tyrosine kinase inhibitor, and this drug was approved for use to treat gastrointestinal stromal tumor and advanced renal cell carcinoma. It has also been shown to be... -
- CITED
-
- Close
- SHARE
-
- Close
- Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis
-
Yoon SH, Kim KH, Choi J, Kim GM, Kim JH, Kim HS, Park YN, Rha SY
- KMID: 2270809
- Cancer Res Treat.
- 2010 Sep;42(3):180-184.
The proper dose and schedule of sunitinib have yet to be established for patients with metastatic renal cell carcinoma (RCC) on hemodialysis. We reviewed two patients with metastatic RCC on... -
- CITED
-
- Close
- SHARE
-
- Close
- Gastrointestinal Stromal Tumor
-
Kim YJ, Kim SS
- KMID: 2249541
- Korean J Helicobacter Up Gastrointest Res.
- 2011 Sep;11(2):82-89.
- doi: 10.7704/kjhugr.2011.11.2.82
Gastrointestinal stromal tumor (GIST) is a relatively rare disease accounted for less than 1% of gastrointestinal tumors. In the past, surgery is the only reliable therapy for the locoregional GISTs.... -
- CITED
-
- Close
- SHARE
-
- Close
- Biopsy-Proven Immune Complex Glomerulonephritis Associated with Sunitinib in a Patient with a Gastrointestinal Stromal Tumor
-
Lee H, Lee HR, Oh KH, Moon KC, Ahn C, Kim S, Bang YJ
- KMID: 2252987
- Korean J Nephrol.
- 2010 Sep;29(5):644-649.
Sunitinib, a multi-targeted tyrosine kinase inhibitor, is used for the treatment of renal cell carcinoma and gastrointestinal stromal tumors. Many adverse effects associated with sunitinib, including hypertension, proteinuria, and thrombotic... -
- CITED
-
- Close
- SHARE
-
- Close
